Literature DB >> 29934195

Parkinsonism in a population-based study of individuals aged 75+ years: The Pietà study.

Thiago Cardoso Vale1, Maira Tonidandel Barbosa2, Elisa de Paula França Resende3, Débora Palma Maia4, Mauro César Quintão Cunningham4, Henrique Cerqueira Guimarães3, João Carlos Barbosa Machado5, Antônio Lucio Teixeira3, Francisco Cardoso4, Paulo Caramelli6.   

Abstract

INTRODUCTION: Parkinsonism is one of the most prevalent neurological syndromes in the elderly. There are only a few epidemiological studies focusing on parkinsonism in oldest-old individuals, particularly in Latin America. This study aims to investigate the prevalence and characteristics of parkinsonism in subjects aged 75 + years living in the community.
METHODS: The Pietà study is a population-based investigation on brain aging conducted in Caeté, southeast Brazil. A sample composed of 610 community-dwelling individuals aged 75 + years (48.7% of the total population within this age range) underwent clinical, neurological, cognitive and functional assessments.
RESULTS: The sample comprised mostly women (61.5%), with mean age of 83.3 years and mean schooling of 2.5 years. Parkinsonism was identified in 65 subjects (crude prevalence = 10.7%). Parkinson's disease, Parkinsonism + dementia syndrome, drug-induced parkinsonism, vascular parkinsonism and Lewy-body dementia were identified in, respectively, 19 (29.2%), 19 (29.2%), 8 (12.3%), 4 (6.1%) and 1 (1.5%) subjects. In 14 individuals (21.5%), the etiology of parkinsonism could not be determined. The most important vascular risk factor was hypertension (64.6%). Cognitive evaluation disclosed dementia in 37 (56.9%) subjects. Mean Pfeffer's functional activities questionnaire score was 12.2 points and 22 (33.8%) subjects were impaired in basic activities of daily living.
CONCLUSION: Parkinsonism was common in this oldest-old population, being associated with dementia and vascular risk factors, particularly hypertension. Different confounders, such as concomitant dementia and exposure to anti-dopaminergic drugs, were present in this population, challenging the definition of causes of parkinsonism.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29934195     DOI: 10.1016/j.parkreldis.2018.06.030

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  5 in total

Review 1.  Is Braak staging valid for all types of Parkinson's disease?

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2018-06-25       Impact factor: 3.575

2.  Prevalence and incidence of Parkinson's disease and other forms of parkinsonism in a cohort of elderly individuals in Southern Brazil: protocol for a population-based study.

Authors:  Gabriela Magalhães Pereira; Nayron Medeiros Soares; Neide Maria Bruscato; Emilio Hideyuki Moriguchi; João Senger; Berenice Maria Werle; Rosa Maria Martins de Almeida; Artur Francisco Schumacher-Schuh; Carlos Roberto de Mello Rieder
Journal:  BMJ Open       Date:  2021-12-15       Impact factor: 2.692

3.  Protective Effect of Renin-Angiotensin System Inhibitors on Parkinson's Disease: A Nationwide Cohort Study.

Authors:  Youngkwon Jo; Seungyeon Kim; Byoung Seok Ye; Euni Lee; Yun Mi Yu
Journal:  Front Pharmacol       Date:  2022-03-03       Impact factor: 5.810

Review 4.  Recognition and Management of Antipsychotic-Induced Parkinsonism in Older Adults: A Narrative Review.

Authors:  Sharadha Wisidagama; Abiram Selladurai; Peter Wu; Marco Isetta; Jordi Serra-Mestres
Journal:  Medicines (Basel)       Date:  2021-05-26

5.  Trimetazidine Use and the Risk of Parkinsonism: A Nationwide Population-Based Study.

Authors:  Seungyeon Kim; Yun Mi Yu; Jeongyoon Kwon; Kyeong Hye Jeong; Jeong Sang Lee; Euni Lee
Journal:  Int J Environ Res Public Health       Date:  2020-10-04       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.